CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
Acetaminophen liquid formulation +1 moredrug
Likely dose
Acetaminophen liquid formulation 15mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01246713
NCT01246713N/ACompleted
CompareCT.gov

Effect on Acetaminophen Metabolism by Liquid Formulations: Do Excipients in Liquid Formulation Prevent Production of Toxic Metabolites?

Beth Israel Deaconess Medical Center·interventional·Posted Nov 23, 2010·Updated May 8, 2017

In Brief

A clinical study evaluating Acetaminophen liquid formulation and Acetaminophen solid formulation for Acetaminophen Metabolism and 2 related conditions. Completed, enrolled 15 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether excipients in the liquid formulation of acetaminophen prevent the formation of the toxic metabolites of acetaminophen.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcetaminophen Metabolism, Acetaminophen Poisoning, Drug Metabolism by Excipients
CountriesUnited States
CollaboratorsHarvard University, National Center for Research Resources (NCRR)

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedNov 23, 2010
Enrollment StartDec 1, 2010
Primary CompletionMay 1, 2011
Study CompletionJul 1, 2012
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 15.6 years ago

Interventions

Acetaminophen liquid formulationdrug

Subjects in this arm will receive a 15mg/kg dose of a solid acetaminophen formulation.

Acetaminophen solid formulationdrug

Subjects in this arm will receive a 15mg/kg dose of a solid acetaminophen formulation.